Clinical Trial Update: Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase II clinical trial of PRL3-ZUMAB in advanced solid tumors is currently recruiting, with planned investigations in gastric cancer and hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• PRL3-ZUMAB

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Gastric Cancer, Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING